Filing Details

Accession Number:
0000902664-25-003345
Form Type:
13G Filing
Publication Date:
2025-08-03 20:00:00
Filed By:
Davidson Kempner
Company:
Biora Therapeutics Inc. (NASDAQ:BIOR)
Filing Date:
2025-08-04
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
M.H. Davidson & Co. 0 25,624 0.56%
Davidson Kempner Arbitrage, Equities and Relative Value LP 0 880,603 9.90%
Davidson Kempner Capital Management LP 0 906,227 9.90%
Anthony A. Yoseloff 0 906,227 9.90%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Includes 24,033 shares of Common Stock issuable upon conversion of notes. As more fully described in Item 4, the reported securities are subject to a 9.90% blocker. The number of shares of Common Stock in rows (6), (8) and (9) and the percentage in row (11) reflect the conversion in full of the notes reported on this cover page, however, the ability to convert such securities at any given time is subject to the 9.90% Blocker which applies to the beneficial ownership of the Reporting Persons in the aggregate.


SCHEDULE 13G



Comment for Type of Reporting Person:  Includes 827,144 shares of Common Stock issuable upon conversion of notes. As more fully described in Item 4, the reported securities are subject to a 9.90% blocker and the percentage set forth in row (11) gives effect to such blocker. However, rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon the conversion in full of the reported securities and do not give effect to such blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blocker, is less than the number of securities reported in rows (6), (8) and (9).


SCHEDULE 13G



Comment for Type of Reporting Person:  Includes 851,177 shares of Common Stock issuable upon conversion of notes. As more fully described in Item 4, the reported securities are subject to a 9.90% blocker and the percentage set forth in row (11) gives effect to such blocker. However, rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon the conversion in full of the reported securities and do not give effect to such blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blocker, is less than the number of securities reported in rows (6), (8) and (9).


SCHEDULE 13G



Comment for Type of Reporting Person:  Includes 851,177 shares of Common Stock issuable upon conversion of notes. As more fully described in Item 4, the reported securities are subject to a 9.90% blocker and the percentage set forth in row (11) gives effect to such blocker. However, rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon the conversion in full of the reported securities and do not give effect to such blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blocker, is less than the number of securities reported in rows (6), (8) and (9).


SCHEDULE 13G


 
M.H. Davidson & Co.
 
Signature:/s/ Anthony A. Yoseloff
Name/Title:Anthony A. Yoseloff, Executive Managing Member of Davidson Kempner Liquid GP Topco LLC, Managing Member of CO GP, General Partner of CO
Date:08/04/2025
 
Davidson Kempner Arbitrage, Equities and Relative Value LP
 
Signature:/s/ Anthony A. Yoseloff
Name/Title:Anthony A. Yoseloff, Executive Managing Member of Davidson Kempner Liquid GP Topco LLC, Managing Member of DKAERV GP, General Partner of DKAERV
Date:08/04/2025
 
Davidson Kempner Capital Management LP
 
Signature:/s/ Anthony A. Yoseloff
Name/Title:Anthony A. Yoseloff, Executive Managing Member
Date:08/04/2025
 
Anthony A. Yoseloff
 
Signature:/s/ Anthony A. Yoseloff
Name/Title:Anthony A. Yoseloff, Individually
Date:08/04/2025